CL2014001156A1 - Metodo para reducir el nivel de acido urico en un sujeto con funcion renal dañada administrando un compuesto de formula (i). - Google Patents
Metodo para reducir el nivel de acido urico en un sujeto con funcion renal dañada administrando un compuesto de formula (i).Info
- Publication number
- CL2014001156A1 CL2014001156A1 CL2014001156A CL2014001156A CL2014001156A1 CL 2014001156 A1 CL2014001156 A1 CL 2014001156A1 CL 2014001156 A CL2014001156 A CL 2014001156A CL 2014001156 A CL2014001156 A CL 2014001156A CL 2014001156 A1 CL2014001156 A1 CL 2014001156A1
- Authority
- CL
- Chile
- Prior art keywords
- administering
- subject
- compound
- formula
- level
- Prior art date
Links
- 206010062237 Renal impairment Diseases 0.000 title 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 231100000857 poor renal function Toxicity 0.000 title 1
- 229940116269 uric acid Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/059425 WO2013066352A1 (en) | 2011-11-04 | 2011-11-04 | Methods for treating gout in patient subpopulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014001156A1 true CL2014001156A1 (es) | 2015-01-16 |
Family
ID=48192536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014001156A CL2014001156A1 (es) | 2011-11-04 | 2014-05-02 | Metodo para reducir el nivel de acido urico en un sujeto con funcion renal dañada administrando un compuesto de formula (i). |
Country Status (14)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104602686A (zh) * | 2012-04-13 | 2015-05-06 | 西玛贝医药公司 | 利用卤芬酯或卤芬酸以及抗炎剂治疗痛风患者中高尿酸血症的方法 |
| CN105851522A (zh) * | 2014-07-25 | 2016-08-17 | 许伟琦 | 一种防止尿路结石的饲料 |
| CN105920022A (zh) * | 2016-05-12 | 2016-09-07 | 成都易创思生物科技有限公司 | 一种抗痛风药物复方制剂 |
| WO2019082335A1 (ja) * | 2017-10-26 | 2019-05-02 | 大塚製薬株式会社 | イノシトールリン酸含有組成物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4250191A (en) * | 1978-11-30 | 1981-02-10 | Edwards K David | Preventing renal failure |
| US6262118B1 (en) * | 1999-06-04 | 2001-07-17 | Metabolex, Inc. | Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia |
| CN102643241B (zh) * | 2007-11-27 | 2015-01-21 | 亚德生化公司 | 化合物和组合物以及使用方法 |
-
2011
- 2011-11-04 BR BR112014010693-2A patent/BR112014010693A2/pt not_active IP Right Cessation
- 2011-11-04 CA CA2859689A patent/CA2859689C/en not_active Expired - Fee Related
- 2011-11-04 NZ NZ624714A patent/NZ624714A/en not_active IP Right Cessation
- 2011-11-04 EP EP11875027.2A patent/EP2775835A4/en not_active Withdrawn
- 2011-11-04 MX MX2014005399A patent/MX354846B/es active IP Right Grant
- 2011-11-04 AU AU2011380509A patent/AU2011380509B2/en not_active Ceased
- 2011-11-04 CN CN201180076189.7A patent/CN104066323A/zh active Pending
- 2011-11-04 SG SG11201402027PA patent/SG11201402027PA/en unknown
- 2011-11-04 KR KR1020147015209A patent/KR101848122B1/ko not_active Expired - Fee Related
- 2011-11-04 JP JP2014541012A patent/JP6047172B2/ja not_active Expired - Fee Related
- 2011-11-04 WO PCT/US2011/059425 patent/WO2013066352A1/en active Application Filing
-
2014
- 2014-04-30 IL IL232385A patent/IL232385A/en active IP Right Grant
- 2014-05-02 CL CL2014001156A patent/CL2014001156A1/es unknown
- 2014-05-16 ZA ZA2014/03574A patent/ZA201403574B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140123927A (ko) | 2014-10-23 |
| KR101848122B1 (ko) | 2018-04-11 |
| IL232385A0 (en) | 2014-06-30 |
| MX2014005399A (es) | 2015-04-08 |
| CA2859689A1 (en) | 2013-05-10 |
| NZ624714A (en) | 2016-01-29 |
| WO2013066352A1 (en) | 2013-05-10 |
| EP2775835A4 (en) | 2015-07-29 |
| JP2014532759A (ja) | 2014-12-08 |
| MX354846B (es) | 2018-03-22 |
| BR112014010693A2 (pt) | 2020-11-10 |
| SG11201402027PA (en) | 2014-09-26 |
| EP2775835A1 (en) | 2014-09-17 |
| CN104066323A (zh) | 2014-09-24 |
| CA2859689C (en) | 2018-05-22 |
| JP6047172B2 (ja) | 2016-12-21 |
| AU2011380509B2 (en) | 2016-05-19 |
| ZA201403574B (en) | 2015-11-25 |
| AU2011380509A1 (en) | 2014-05-29 |
| IL232385A (en) | 2017-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2685832T3 (pl) | Stabilizowane roztwory kwasu podhalogenawego | |
| ZA201404461B (en) | Process to prepare levulinic acid | |
| IL227754B (en) | Analogues of 4-hydroxybutyric acid with deuterium | |
| CL2014002622A1 (es) | Un metodo para modificar beta-estuco utilizando acido dietilen-triamin-pentaacetico. | |
| EP2741376A4 (en) | CONNECTORS FOR PREVENTING THE DISABLING | |
| EP2757093A4 (en) | GUANIDINOBENZOESÄUREVERBINDUNG | |
| DK2390914T3 (da) | Indretning af to forbindelsespartnere med en lavtemperatur-tryksinterforbindelse samt fremgangsmåde til dens fremstilling | |
| CO6910182A2 (es) | Producción mejorada de ácido nítrico | |
| HUE043339T2 (hu) | Módszer a PML kockázatának megállapítására | |
| DK2771475T3 (da) | Fremgangsmåde til omdannelse af lignocellulose til en organisk syre med recycling af opløste salte | |
| BR112013031365A2 (pt) | método para produzir um composto | |
| FR2974862B1 (fr) | Pompe a engrenage | |
| PT2666015T (pt) | Utilização de estatmina como um biomarcador da resposta farmacológica a furazanobenzimidazolos | |
| CL2014001156A1 (es) | Metodo para reducir el nivel de acido urico en un sujeto con funcion renal dañada administrando un compuesto de formula (i). | |
| SMT201600199B (it) | Perfezionamenti relativi a pompe per pene | |
| PL2677887T3 (pl) | Zmniejszanie wytrącania kwasu sorbinowego | |
| IL231546A (en) | Salts of sulfonic acid of imidazoles conjugated with heterocyclic amide | |
| SMT201600071B (it) | Derivato di acido pirrolidina-3-ilacetico | |
| BR112014025158A2 (pt) | método para produzir um composto. | |
| BR112013030888A2 (pt) | método para produzir um composto. | |
| PT2734736T (pt) | Melhorias a bombas e componentes para as mesmas | |
| CO6811871A2 (es) | Proceso para la cristalización de un compuesto soluble en agua | |
| EP2768812A4 (en) | BOSENTAN ACID ADDITION SALTS | |
| BR112013015002A2 (pt) | método para obter um composto | |
| BR112013015003A2 (pt) | método para obter um composto |